Pitocin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Pitocin
Generic name
OXYTOCIN
Manufacturer
Par Health USA, LLC
Product type
HUMAN PRESCRIPTION DRUG
SPL set ID
dddcdcc3-cd4d-4573-98ac-9468bea23a8b
SPL ID
d3d010b0-5caf-4f64-9ba6-1d1eeb3dc0b2
Version
10
Effective date
2024-08-12
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:54:59
Harmonized routes table
Harmonized routes
INTRAVENOUS

Boxed warning cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Boxed warning sections page 1 of 1 · 1 matching rows.

boxed warning

IMPORTANT NOTICE Elective induction of labor is defined as the initiation of labor in a pregnant individual who has no medical indications for induction. Since the available data are inadequate to evaluate the benefits-to-risks considerations, Pitocin is not indicated for elective induction of labor.

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Pitocin, when given for induction of labor or augmentation of uterine activity, should be administered only by the intravenous route and with adequate medical supervision in a hospital.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 3 matching rows.

adverse reactions

ADVERSE REACTIONS The following adverse reactions have been reported in the mother: Anaphylactic reaction Premature ventricular contractions Postpartum hemorrhage Pelvic hematoma Cardiac arrhythmia Subarachnoid hemorrhage Fatal afibrinogenemia Hypertensive episodes Nausea Rupture of the uterus Vomiting Excessive dosage or hypersensitivity to the drug may result in uterine hypertonicity, spasm, tetanic contraction, or rupture of the uterus. The possibility of increased blood loss and afibrinogenemia should be kept in mind when administering the drug. Severe water intoxication with convulsions and coma has occurred, associated with a slow oxytocin infusion over a 24-hour period. Maternal death due to oxytocin-induced water intoxication has been reported. The following adverse reactions have been reported in the fetus or neonate: Due to induced uterine motility: Due to use of oxytocin in the mother: Bradycardia Low Apgar scores at five minutes Premature ventricular contractions and other arrhythmias Neonatal jaundice Permanent CNS or brain damage Neonatal retinal hemorrhage Fetal death Neonatal seizures have been reported with the use of Pitocin. For medical advice about adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact Endo at 1-800-828-9393 or FDA at 1-800-FDA-1088 (1-800-332-1088) or www.fda.gov/medwatch.

adverse reactions table

<table><col/><col/><tbody><tr><td> <paragraph>Anaphylactic reaction </paragraph></td><td> <paragraph>Premature ventricular contractions </paragraph></td></tr><tr><td> <paragraph>Postpartum hemorrhage </paragraph></td><td> <paragraph>Pelvic hematoma </paragraph></td></tr><tr><td> <paragraph>Cardiac arrhythmia </paragraph></td><td> <paragraph>Subarachnoid hemorrhage </paragraph></td></tr><tr><td> <paragraph>Fatal afibrinogenemia </paragraph></td><td> <paragraph>Hypertensive episodes </paragraph></td></tr><tr><td> <paragraph>Nausea </paragraph></td><td> <paragraph>Rupture of the uterus </paragraph></td></tr><tr><td> <paragraph>Vomiting </paragraph></td><td> </td></tr></tbody></table>

adverse reactions table

<table><col/><col/><tbody><tr><td> <paragraph>Due to induced uterine motility: </paragraph></td><td> <paragraph>Due to use of oxytocin in the mother: </paragraph></td></tr><tr><td> <paragraph> Bradycardia </paragraph></td><td> <paragraph> Low Apgar scores at five minutes </paragraph></td></tr><tr><td> <paragraph> Premature ventricular contractions and other arrhythmias </paragraph></td><td> <paragraph> Neonatal jaundice </paragraph></td></tr><tr><td> <paragraph> Permanent CNS or brain damage </paragraph></td><td> <paragraph> Neonatal retinal hemorrhage </paragraph></td></tr><tr><td> <paragraph> Fetal death </paragraph></td><td> </td></tr><tr><td> <paragraph> Neonatal seizures have been reported with the use of Pitocin. </paragraph></td><td> </td></tr></tbody></table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.